Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Raskob

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 12, 2016
Global public awareness of venous thromboembolism: replyG Raskob, A M Wendelboe
Journal of the Royal Society of Medicine|April 1, 1982
Long-term anticoagulant therapy prevents recurrent venous thromboembolismG Raskob, R Jay, R Hull
Drugs|November 1, 1985
Risk of haemorrhage associated with long term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Chest|February 1, 1989
Hemorrhagic complications of long-term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Chest|February 1, 1986
Hemorrhagic complications of long-term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Annals of Internal Medicine|September 1, 1994
Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive managementP D Stein, R D Hull, G Raskob
Therapeutic Drug Monitoring|May 1, 1990
Predicting the daily prothrombin time response to warfarinL Farrow, D Mungall, G Raskob, et al.
Chest|October 1, 1992
Hemorrhagic complications of anticoagulant treatmentM N Levine, J Hirsh, S Landefeld, et al.
Chest|October 1, 1995
Hemorrhagic complications of anticoagulant treatmentM N Levine, G Raskob, S Landefeld, et al.
Chest|February 7, 2001
Hemorrhagic complications of anticoagulant treatmentM N Levine, G Raskob, S Landefeld, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|February 12, 2016
Global public awareness of venous thromboembolism: replyG Raskob, A M Wendelboe
Journal of the Royal Society of Medicine|April 1, 1982
Long-term anticoagulant therapy prevents recurrent venous thromboembolismG Raskob, R Jay, R Hull
Drugs|November 1, 1985
Risk of haemorrhage associated with long term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Chest|February 1, 1989
Hemorrhagic complications of long-term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Chest|February 1, 1986
Hemorrhagic complications of long-term anticoagulant therapyM N Levine, G Raskob, J Hirsh
Annals of Internal Medicine|September 1, 1994
Risks for major bleeding from thrombolytic therapy in patients with acute pulmonary embolism. Consideration of noninvasive managementP D Stein, R D Hull, G Raskob
Therapeutic Drug Monitoring|May 1, 1990
Predicting the daily prothrombin time response to warfarinL Farrow, D Mungall, G Raskob, et al.
Chest|October 1, 1992
Hemorrhagic complications of anticoagulant treatmentM N Levine, J Hirsh, S Landefeld, et al.
Chest|October 1, 1995
Hemorrhagic complications of anticoagulant treatmentM N Levine, G Raskob, S Landefeld, et al.
Chest|February 7, 2001
Hemorrhagic complications of anticoagulant treatmentM N Levine, G Raskob, S Landefeld, et al.
Pageof 3